UCP1 and breast cancer: Interestingly, microscopical examination of BAT sections immunostained for UCP1 revealed a more active BAT appearance (i.e., smaller lipid droplets) together with a greater UCP1 positivity in the treated HFD-fed groups, especially those receiving BC, compared with the HF control group (Figure 4C).